The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BELLE-3: A Phase III study of the pan-phosphatidylinositol 3-kinase (PI3K) inhibitor buparlisib (BKM120) with fulvestrant in postmenopausal women with HR+/HER2– locally advanced/metastatic breast cancer (BC) pretreated with aromatase inhibitors (AIs) and refractory to mTOR inhibitor (mTORi)-based treatment.
 
Angelo Di Leo
Honoraria - AstraZeneca; Eisai; Genomic Health; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Novartis; Pfizer; Roche
 
Eva Ciruelos
No Relationships to Disclose
 
Wolfgang Janni
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Novartis
 
Per Eystein Lonning
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Astellas Pharma; Novartis
 
Ruth O'Regan
Honoraria - Genomic Health; Novartis; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; BIND Biosciences; Celgene; Johnson & Johnson; Novartis; Pfizer
Research Funding - Genentech (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - BIND Biosciences; Celgene; Genomic Health; Novartis; Roche
 
Michael Hubalek
Honoraria - Novartis; Roche Pharma AG
 
Tibor Csõszi
No Relationships to Disclose
 
Thomas Decker
Consulting or Advisory Role - Novartis; Roche Pharma AG
Speakers' Bureau - Novartis; Roche Pharma AG
 
Vivianne C. Tjan-Heijnen
Research Funding - AstraZeneca; Boehringer Ingelheim; Eisai; Novartis; Roche Pharma AG
 
Denis Weber
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Mona El-Hashimy
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Sasikiran Goteti
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Cristian Massacesi
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Thomas Denis Bachelot
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Novartis; Roche Pharma AG; SERVIER
Research Funding - Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG